On Monday, Geron Corp (NASDAQ: GERN) opened lower -3.06% from the last session, before settling in for the closing price of $4.25. Price fluctuations for GERN have ranged from $1.64 to $5.34 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 46.26%. Company’s average yearly earnings per share was noted 17.81% at the time writing. With a float of $554.18 million, this company’s outstanding shares have now reached $604.50 million.
The extent of productivity of a business whose workforce counts for 141 workers is very important to gauge. In terms of profitability, gross margin is 96.73%, operating margin of -706.95%, and the pretax margin is -683.91%.
Geron Corp (GERN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Geron Corp is 8.32%, while institutional ownership is 70.06%. The most recent insider transaction that took place on Jul 08 ’24, was worth 3,073,004. In this transaction EVP, Chief Operating Officer of this company sold 674,348 shares at a rate of $4.56, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 10 ’24, when Company’s EVP, Chief Medical Officer sold 287,900 for $4.63, making the entire transaction worth $1,334,129. This insider now owns 0 shares in total.
Geron Corp (GERN) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.09 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.1) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.00% during the next five years compared to -16.08% drop over the previous five years of trading.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Check out the current performance indicators for Geron Corp (GERN). In the past quarter, the stock posted a quick ratio of 2.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 83.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.32, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.07 in one year’s time.
Technical Analysis of Geron Corp (GERN)
The latest stats from [Geron Corp, GERN] show that its last 5-days average volume of 15.6 million was superior to 10.45 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 46.15%. Additionally, its Average True Range was 0.20.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 20.74%, which indicates a significant decrease from 38.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.26% in the past 14 days, which was lower than the 46.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.30, while its 200-day Moving Average is $3.81. Now, the first resistance to watch is $4.22. This is followed by the second major resistance level at $4.32. The third major resistance level sits at $4.38. If the price goes on to break the first support level at $4.05, it is likely to go to the next support level at $3.99. Assuming the price breaks the second support level, the third support level stands at $3.89.
Geron Corp (NASDAQ: GERN) Key Stats
There are currently 602,796K shares outstanding in the company with a market cap of 2.47 billion. Presently, the company’s annual sales total 240 K according to its annual income of -184,130 K. Last quarter, the company’s sales amounted to 880 K and its income totaled -67,380 K.
